The Neurogenx 4000Pro with upgraded NervePro 2.0 firmware is the most advanced electromedical treatment for nerve pain. The innovative NervePro 2.0 offers a unique biosimilar energy with paced delivery sweeping the highest frequencies ever up to 60,000 Hz.
The Neurogenx NervePro 2.0 is a cutting-edge electromedical treatment successful for 4 out of 5 patients with neuropathy and chronic nerve conditions. It generates a sophisticated electronic signal with a wide frequency band to safely treat the pain, tingling, burning, and numbness that are the hallmark symptoms of neuropathy and chronic nerve conditions.
Neurogenx NervePro 2.0 treatments effectively eliminate or significantly reduce neuropathy symptoms while improving sensation and helping to regrow nerve fibers. The Neurogenx NervePro 2.0 offers the most biosimilar energy delivered with the highest frequencies ever, up to 60,000 Hz.
This stand-alone treatment can provide restorative results that go beyond pain management for patients with complex neuropathic issues that are not responding to traditional protocols or for patients who no longer wish to rely on narcotic solutions.
Treatment results from the Neurogenx NervePro 2.0 are long-lasting and can be permanent if the patient is able to address the underlying cause of their nerve pain – such as better management of their diabetes. Improvement is often seen within 3-4 visits, in addition, many patients report that their pain levels continue to improve even after their treatment course is complete: some have seen additional improvement as long as a year post-treatment. The treatment is equally effective whether patients have new nerve pain or have suffered from symptoms for 20 years or more.
Independent laboratory test results conclusively demonstrate dramatic increases in nerve fiber density following treatment with the Neurogenx NervePro 2.0. Epidermal Nerve Fiber Density (ENFD) tests show an average increase of 165.4% in nerve fiber density, with some patients having increases as high as 395%. ENFD testing is the gold standard in diagnosing and monitoring small fiber peripheral neuropathy (the type of neuropathy responsible for pain, burning, and numbness.) Other routine tests, such as EMG and nerve conduction studies, are often normal in patients with small fiber neuropathy. ENFD testing is also important because it allows clinicians to objectively monitor a patient’s improvement in response to treatment.
Patient results tracked for more than a decade.
Prove-it for yourself in the first 12 months at $99 per month
OR We'll Buy-it Back!
Extended warranty that offers Lifetime Protection for all Neurogenx technology through a monthly supply replenishment.
The Top 14 Most-Asked Questions About The Neurogenx Treatment!
